Table 3 -.
Comparison of conservative and invasive therapy in younger patients
| Variables | Cons. Group (N=286) | Inv. Group (N=754) | P-value | Odds-ratio (95% CI) |
|---|---|---|---|---|
| Hx MI (%) | 29.0 | 25.9 | 0.304 | 0.85 (0.63 to 1.15) |
| Hx PCI (%) | 11.2 | 11.3 | 0.969 | 1.0 (0.65 to 1.55) |
| Hx CABG (%) | 16.1 | 9.3 | 0.002 | 0.53 (0.36 to 0.78) |
| Hx HF (%) | 7.7 | 4.2 | 0.025 | 0.53 (0.30 to 0.93) |
| Hx DM (%) | 24.1 | 26.7 | 0.406 | 1.14 (0.83 to 1.57) |
| Hx stroke (%) | 2.8 | 2.8 | 0.992 | 1.0 (0.47 to 2.27) |
| Hx hypertension (%) | 62.2 | 65.4 | 0.400 | 1.13 (0.85 to 1.50) |
| Family Hx CAD (%) | 26.6 | 32.9 | 0.049 | 1.35 (1.00 to 1.83) |
| Hx hypercholesterolemia (%) | 40.6 | 51.9 | 0.001 | 1.58 (1.20 to 2.08) |
| Hx smoking (%) | 34.6 | 39.7 | 0.135 | 1.24 (0.93 to 1.65) |
| ST-elevation MI (%) | 43.9 | 64.6 | <0.001 | 2.33 (1.76 to 3.10) |
| Anterior MI (%) | 37.4 | 44.3 | 0.045 | 1.33 (1.01 to 1.76) |
| Fibrinolytic (%) | 26.2 | 25.5 | 0.802 | 1.96 (0.71 to 1.31) |
| Men (%) | 70.6 | 78.9 | 0.005 | 1.56 (1.14 to 2.12) |
Legend as for Table 1